PARP Inhibitors: Extending Benefit Beyond <i>BRCA</i>-Mutant Cancers
Crossref DOI link: https://doi.org/10.1158/1078-0432.CCR-18-0968
Published Online: 2019-07-01
Published Print: 2019-07-01
Update policy: https://doi.org/10.1158/crossmark_policy
Pilié, Patrick G.
Gay, Carl M.
Byers, Lauren A.
O'Connor, Mark J. https://orcid.org/0000-0003-1823-625X
Yap, Timothy A.
Funding for this research was provided by:
University of Texas MD Anderson Cancer Center (CA016672)
